1. Home
  2. HCWB vs FRSX Comparison

HCWB vs FRSX Comparison

Compare HCWB & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.16

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$0.82

Market Cap

3.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCWB
FRSX
Founded
2018
N/A
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.4M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
HCWB
FRSX
Price
$1.16
$0.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 748.2K
71.7K
Earning Date
11-13-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $4,099,750.00
N/A
Revenue This Year
$12,215.61
$90.14
Revenue Next Year
N/A
$154.13
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$0.73
52 Week High
$23.94
$3.00

Technical Indicators

Market Signals
Indicator
HCWB
FRSX
Relative Strength Index (RSI) 26.99 29.46
Support Level $1.14 $0.78
Resistance Level $1.73 $1.47
Average True Range (ATR) 0.11 0.08
MACD 0.00 -0.01
Stochastic Oscillator 1.70 17.50

Price Performance

Historical Comparison
HCWB
FRSX

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications. The company designs, develops, and commercializes in-line-of-sight vision systems and beyond-line-of-sight accident prevention solutions through its subsidiaries. Its solutions are based on stereo vision, 3D perception, and V2X technologies, aimed at improving safety by enabling accurate obstacle detection and real-time alerts. The company targets multiple industries, including automotive, defense, agriculture, and heavy equipment.

Share on Social Networks: